Pyroglutamyl Peptidase II Inhibition Enhances the Analeptic Effect of Thyrotropin-Releasing Hormone in the Rat Medial Septum

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2012-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/jpet.112.192278PMID 22532627
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hunting for peptide substrates of prolyl oligopeptidase: classical versus non-classical bioactive peptides.

  2011cited by this paper
• Alcoholism: a systems approach from molecular physiology to addictive behavior.

  2009influential reference
• Issues About the Physiological Functions of Prolyl Oligopeptidase Based on Its Discordant Spatial Association With Substrates and Inconsistencies Among mRNA, Protein Levels, and Enzymatic Activity

  2009cited by this paper
• Tanycyte pyroglutamyl peptidase II contributes to regulation of the hypothalamic-pituitary-thyroid axis through glial-axonal associations in the median eminence.

  2009influential reference
• Anterior pituitary pyroglutamyl peptidase II activity controls TRH-induced prolactin release.

  2008influential reference
• Synthesis of the phosphinic analogue of thyrotropin releasing hormone.

  2008cited by this paper
• Noradrenergic modulation of arousal.

  2008cited by this paper
• Characterization of membrane‐bound prolyl endopeptidase from brain

  2008cited by this paper
• Neural substrates of awakening probed with optogenetic control of hypocretin neurons

  2007cited by this paper
• Thyrotropin-releasing hormone (TRH) in the neuroaxis: therapeutic effects reflect physiological functions and molecular actions.

  2007cited by this paper
• Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone.

  2007influential reference
• Amygdala kindling differentially regulates the expression of the elements involved in TRH transmission.

  2006influential reference
• Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice.

  2005cited by this paper
• A truncated isoform of pyroglutamyl aminopeptidase II produced by exon extension has dominant‐negative activity

  2005cited by this paper
• The Thyrotropin-Releasing Hormone (TRH) Hypothesis of Homeostatic Regulation: Implications for TRH-Based Therapeutics

  2003cited by this paper
• Dimerization and Phosphorylation of Thyrotropin-releasing Hormone Receptors Are Modulated by Agonist Stimulation*

  2002cited by this paper
• Role of TRH receptors as possible mediators of analeptic actions of TRH-like peptides.

  2002cited by this paper
• Pharmacologically distinct binding sites in rat brain for [3H]thyrotropin-releasing hormone (TRH) and [3H][3-methyl-histidine(2)]TRH.

  2002cited by this paper
• Differential Responses of Thyrotropin-Releasing Hormone (TRH) Neurons to Cold Exposure or Suckling Indicate Functional Heterogeneity of the TRH System in the Paraventricular Nucleus of the Rat Hypothalamus

  2001cited by this paper
• The osmotic component of ethanol and urea action is critical for their immediate stimulation of thyrotropin-releasing hormone (TRH) release from rat brain septum.

  2001cited by this paper
• TRH-R2 exhibits similar binding and acute signaling but distinct regulation and anatomic distribution compared with TRH-R1.

  2000cited by this paper
• Regulation of adenohypophyseal pyroglutamyl aminopeptidase II activity by thyrotropin-releasing hormone and phorbol esters

  2000cited by this paper
• Kinetic Investigation of the Specificity of Porcine Brain Thyrotropin-releasing Hormone-degrading Ectoenzyme for Thyrotropin-releasing Hormone-like Peptides*

  2000influential reference
• Expression of thyrotropin‐releasing hormone receptor 2 (TRH‐R2) in the central nervous system of rats

  2000influential reference
• Three TRH-Like Molecules Are Released from Rat Hypothalamus In Vitro

  1999cited by this paper
• The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme: The Third Element of the Thyrotropin-Releasing Hormone-Signaling System

  1998influential reference
• Region‐specific expression of thyrotrophin‐releasing hormone‐degrading ectoenzyme in the rat central nervous system and pituitary gland

  1998influential reference
• TRH inactivation in the extracellular compartment: role of pyroglutamyl peptidase II.

  1998cited by this paper
• An update on the CNS actions of TRH and its analogs.

  1998cited by this paper
• Expression of the proprotein convertases PC1 and PC2 mRNAs in thyrotropin releasing hormone neurons of the rat paraventricular nucleus of hypothalamus.

  1997cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• Institute of Laboratory Animal Resources.

  1995cited by this paper
• JTP-4819: a novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer.

  1995cited by this paper
• Thyrotropin-releasing hormone: basis and potential for its therapeutic use.

  1995cited by this paper
• Thyrotropin-releasing hormone downregulates pyroglutamyl peptidase II activity in adenohypophyseal cells.

  1994cited by this paper
• Cloning of a cDNA encoding an ectoenzyme that degrades thyrotropin-releasing hormone.

  1994influential reference
• Septal TRH in alcohol-naive P and NP rats and following alcohol challenge.

  1993cited by this paper
• Pyroglutamyl peptidase II inhibition specifically increases recovery of TRH released from rat brain slices.

  1989cited by this paper
• Regional distribution of the membrane-bound pyroglutamate amino peptidase-degrading thyrotropin-releasing hormone in rat brain.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Specific inhibitors of pyroglutamyl peptidase I and prolyl endopeptidase do not change the in vitro release of TRH or its content in rodent brain.

  1987cited by this paper
• Interactions between TRH and ethanol in the medial septum.

  1986cited by this paper
• Autoradiographic localization of thyrotropin-releasing hormone receptors in the rat central nervous system

  1985cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983influential reference
• Thyrotropin releasing hormone

  1982influential reference
• Formation and degradation of deamido-TRH (pyroglutamyl-histidyl-proline) in rat brain after intraventricular injection of TRH.

  1981cited by this paper
• Thyrotropin-releasing hormone: neurogenesis of actions in the pentobarbital narcotized rat.

  1980cited by this paper
• Blood level and brain distribution of thyrotropin-releasing hormone (TRH) determined by radioimmunoassay after intravenous administration in rats.

  1980cited by this paper
• Metabolic clearance of thyrotropin-releasing hormone in the rat in hypothyroid and hyperthyroid states: comparison with serum degradation in vitro.

  1979cited by this paper

• Thyrotropin-Releasing Hormone and Food Intake in Mammals: An Update

  2024cites this paper
• Phosphinic Peptides as Tool Compounds for the Study of Pharmacologically Relevant Zn-Metalloproteases.

  2022cites this paper
• The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?

  2020cites this paper
• Synopsis of recent synthetic methods and biological applications of phosphinic acid derivatives

  2020cites this paper
• Potential chemical transformation of phosphinic acid derivatives and their applications in the synthesis of drugs.

  2019cites this paper
• Mechanism of Action of Prolyl Oligopeptidase (PREP) in Degenerative Brain Diseases: Has Peptidase Activity Only a Modulatory Role on the Interactions of PREP with Proteins?

  2017cites this paper
• [Molecular mechanisms of pidolate magnesium action and its neurotropic affects].

  2016cites this paper
• TGFβ2 regulates hypothalamic Trh expression through the TGFβ inducible early gene-1 (TIEG1) during fetal development.

  2015cites this paper
• TRH regulates action potential shape in cerebral cortex pyramidal neurons.

  2014influential citation
• Transition State Analogues of Enzymatic Reaction as Potential Drugs

  2013cites this paper